Profile picture

Ms Parisa Danaietash

Idorsia Pharmaceuticals, Allschwil (Switzerland)
Follow
Logo ESC

Contributor content

Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension
Presentation
Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources